Contribution of NRG1 Gene Polymorphisms in Temporal Lobe Epilepsy (Q40839066)

24 September 2017

title

Contribution of NRG1 Gene Polymorphisms in Temporal Lobe Epilepsy (English)

1 reference

24 September 2017

1 reference

24 September 2017

Wen-Ye Zhu

1 reference

24 September 2017

Xin He

1 reference

24 September 2017

Ling-Juan Cao

1 reference

24 September 2017

Li-Hong Zhang

1 reference

24 September 2017

Rui-Li Dang

1 reference

24 September 2017

Mi-Mi Tang

1 reference

24 September 2017

Ying Xue

1 reference

24 September 2017

Huan-De Li

1 reference

24 September 2017

publication date

12 June 2015

1 reference

Journal of Child Neurology

24 September 2017

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

271-276

1 reference

Estimation of the burden of active and life-time epilepsy: a meta-analytic approach

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Recent advances in the molecular genetics of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

The hidden genetics of epilepsy-a clinically important new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Schizophrenia and epilepsy: is there a shared susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Catamenial epilepsy: hormonal aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin 1 is a pronociceptive cytokine that is regulated by progesterone in the spinal cord: implications for sex specific pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin-1 enhances depolarization-induced GABA release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Contribution of KCNJ10 gene polymorphisms in childhood epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

Potassium channel genes and benign familial neonatal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073815589757

21 January 2018

Identifiers

DOI

10.1177/0883073815589757

1 reference

24 September 2017

1 reference